SanaCurrents capturing gain after Spectrum’s (SPPI) PDUFA catalyst up 92%; closing out BioXcel (BTAI)
Since SanaCurrents issued a report on Spectrum Pharmaceuticals’ (SPPI) cancer drug poziotinib on February 25, the company’s stock price has climbed 92%, closing [...]